Timing and magnitude of the next wave of COVID-19 in China: lessons from 189 countries and territories

Author:

Niu Beidi,Ji Shuyi,Zhao Shi,Lei Hao

Abstract

AbstractBecause of the fading immunity to COVID-19 and continuous evolution of the SARS-CoV-2 Omicron variants, the next epidemic wave of COVID-19 is inevitable. The Omicron variant has been the cause of several waves of the COVID-19 epidemics in the majority of countries. Thus, lessons from other countries may provide guidance regarding the timing and magnitude of the next COVID-19 wave of the pandemic in China. In this study, the COVID-19 surveillance data from 189 countries that experienced two or more waves of the SARS-CoV-2 Omicron variant were analysed. The median peak timing between the first and second/third waves of the SARS-CoV-2 Omicron variant was 164/243 days. The peaks of the second and third waves were much lower than that of the first wave. The median relative peaks of the second and third compared with the first waves were 14.5% and 11.2%, respectively. The time window between the peak timings of the first and second waves showed no significant rank correlation with the five socioeconomic factors included in this study. However, the relative peak of the second wave increased significantly with gross domestic product per capita (P<0.001), urbanisation rate (P=0.003), population density (P=0.007), and proportion of older adults >65 years (P<0.001), although decreased significantly with the proportion of 0-14 teenagers (P<0.001). In summary, the historical situations and progression of COVID-19 outbreaks in other countries may inform the risk assessment of incoming outbreaks in mainland China; however, the timing and magnitude of the next COVID-19 wave may also be influenced by several unknown factors, including rapid viral evaluation of SARS-CoV-2

Publisher

Cold Spring Harbor Laboratory

Reference23 articles.

1. 全国新型冠状病毒感染诊疗和监测数据概述(2022 年 12 月 9 日至 2023 年 1 6708 23 日) [EB/OL].2023[2023-1-25]. https://weekly.chinacdc.cn/fileCCDCW/cms/news/info/upload/ccdcw-surveillance-202212-202301-cn.pdf

2. Willyard C. How quickly does COVID immunity fade? What scientists know. Nature, 2023.

3. Cao Y , Jian F , Wang J , et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature, 2022: 1–3.

4. Bobrovitz N , Ware H , Ma X , et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. The Lancet Infectious Diseases, 2023.

5. World Bank. World Bank Open Data. 28 February, 2023. Available at: https://data.worldbank.org.cn/.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3